Vaccine elicitation and structural basis for antibody protection against alphaviruses

疫苗诱导及针对甲病毒抗体保护的结构基础

阅读:3
作者:Matthew S Sutton,Sergei Pletnev,Victoria Callahan,Sungyoul Ko,Yaroslav Tsybovsky,Tatsiana Bylund,Ryan G Casner,Gabriele Cerutti,Christina L Gardner,Veronica Guirguis,Raffaello Verardi,Baoshan Zhang,David Ambrozak,Margaret Beddall,Hong Lei,Eun Sung Yang,Tracy Liu,Amy R Henry,Reda Rawi,Arne Schön,Chaim A Schramm,Chen-Hsiang Shen,Wei Shi,Tyler Stephens,Yongping Yang,Maria Burgos Florez,Julie E Ledgerwood,Crystal W Burke,Lawrence Shapiro,Julie M Fox,Peter D Kwong,Mario Roederer

Abstract

Alphaviruses are RNA viruses that represent emerging public health threats. To identify protective antibodies, we immunized macaques with a mixture of western, eastern, and Venezuelan equine encephalitis virus-like particles (VLPs), a regimen that protects against aerosol challenge with all three viruses. Single- and triple-virus-specific antibodies were isolated, and we identified 21 unique binding groups. Cryo-EM structures revealed that broad VLP binding inversely correlated with sequence and conformational variability. One triple-specific antibody, SKT05, bound proximal to the fusion peptide and neutralized all three Env-pseudotyped encephalitic alphaviruses by using different symmetry elements for recognition across VLPs. Neutralization in other assays (e.g., chimeric Sindbis virus) yielded variable results. SKT05 bound backbone atoms of sequence-diverse residues, enabling broad recognition despite sequence variability; accordingly, SKT05 protected mice against Venezuelan equine encephalitis virus, chikungunya virus, and Ross River virus challenges. Thus, a single vaccine-elicited antibody can protect in vivo against a broad range of alphaviruses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。